PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
Jakarta · IDR · Healthcare · Diagnostics & Research
IDR 280 (-2.78%) as of
Key statistics
- Market cap
- 385.00B
- P/E (TTM)
- 5.40
- EPS (TTM)
- 51.84
- Dividend yield
- 0.00%
- 52-week range
- 140.00 – 382.00
- Beta
- 0.38
- Revenue (TTM)
- 176.49B
- Profit margin
- 1.16%
- Volume
- 468.40k
About PT Diagnos Laboratorium Utama Tbk
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia, and other bacteria; genomics; homecare services; and inspection panel tests. It also provides clinical pathology, anatomical pathology, and microbiology laboratory; and corporate health and research services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Jakarta Pusat, Indonesia
- Employees
- 87
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.